- Dr Eric Topol Twitter
- Eric J Topol
- Eric Topel Twitter
- Eric Topol Twitter Page
- Eric Topol Md Twitter
- Eric Topole Twitter
Evan D. Muse et al. –
Dr Eric Topol Twitter
“Alexa, what’s my genetic risk for heart disease and should I be taking a statin?” Virtual assistants can guide us through CPR during emergencies and help manage diabetes, so a query into our personal genome is not far off. Genetic profiling is growing with projections that more than a billion people will have their genomes sequenced by 2025. But outside of prenatal and hereditary cancer screening, cancer treatment, and rare disease diagnosis, genetic data are infrequently used for routine preventive or therapeutic medical plans. Consumers typically connect with personal genomic data in isolation and there is poor or absent interoperability between our electronic health records and our genomics. Reviewing a patient’s physiological and medical data in electronic and paper records with limited face-to-face time at each clinic visit can be daunting. The integration of genomic data adds a new level of complexity. To overcome these barriers and bring genomic insights into the process of shared decision making with physicians, new digital tools will take centre stage.
Eric J Topol
Read the full article in The Lancet.
Evan D. Muse et al. –
Gary & Mary West. Twitter Feed: @EricTopol. Endeavor, our institute magazine, is published three times a year and shares the stories behind our. Topol: Well, there's no question about the open science, as well as having that ability to get the word out through Twitter. One of those things, just to mention, is that of all the different.
Eric Topel Twitter
Eric Topol Twitter Page
Eric Topol Md Twitter
“Alexa, what’s my genetic risk for heart disease and should I be taking a statin?” Virtual assistants can guide us through CPR during emergencies and help manage diabetes, so a query into our personal genome is not far off. Genetic profiling is growing with projections that more than a billion people will have their genomes sequenced by 2025. But outside of prenatal and hereditary cancer screening, cancer treatment, and rare disease diagnosis, genetic data are infrequently used for routine preventive or therapeutic medical plans. Consumers typically connect with personal genomic data in isolation and there is poor or absent interoperability between our electronic health records and our genomics. Reviewing a patient’s physiological and medical data in electronic and paper records with limited face-to-face time at each clinic visit can be daunting. The integration of genomic data adds a new level of complexity. To overcome these barriers and bring genomic insights into the process of shared decision making with physicians, new digital tools will take centre stage.
Eric Topole Twitter
Read the full article in The Lancet.